5
Funding Rounds
$263.1m
Money raised
Mammoth Biosciences is an American company based in San Francisco founded on June 1, 2017. Mammoth Biosciences uses CRISPR technology to develop bio-sensing technologies for diagnostics in industries such as healthcare, agriculture, manufacturing, and forensics and genome editing therapeutics.
Industries:
Key people:
- Janice Chen ******@mammoth.bio
- Lucas Harrington *****@mammoth.bio
- Jennifer Doudna ******@berkeley.edu
5
Funding Rounds
$5.1m
Money raised
Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.
2
Funding Rounds
$158.0m
Money raised
Senti Biosciences is a synthetic biology company.
Industries:
Key people:
- Timothy Lu ***.**@sentibio.com
- Philip Lee ******.***@sentibio.com
- Wilson Wong
3
Funding Rounds
$21.5m
Money raised
RoosterBio is a biotechnology company located in Frederick, Maryland, founded by Jon Rowley in 2013 providing standardized stem cell products for R&D, clinical, and commercial use in the regenerative medicine industry.
5
Funding Rounds
$111.8m
Money raised
Orig3n is a biotechnology company developing personalized regenerative medicine treatments based on patient genetic profiles.
2
Funding Rounds
$120.0m
Money raised
Scribe Therapeutics develops molecular engineering solutions for CRISPR-based genetic medicine.
Industries:
Key people:
- Benjamin L. Oakes ***@scribetx.com
- Jennifer Doudna ******@berkeley.edu
- Brett T. Staahl *****@scribetx.com
6
Funding Rounds
$88.0m
Money raised
Prellis Biologics is developing technology to build transplantable human organs and tissues.
6
Funding Rounds
$190.5m
Money raised
Kuur Therapeutics focuses on the development of CAR-NKT cell therapies platform for applications in cancer treatment.
Industries:
Location:
Key people:
8
Funding Rounds
$117.5m
Money raised
Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.
Industries:
Key people:
- Nick Taylor ******@locus-bio.com
- Paul Garofolo ****.********@locus-bio.com
- Charles Gersbach linkedin
5
Funding Rounds
$103.1m
Money raised
Promethera Biosciences is a biotechnology company developing regenerative medicine treatments for liver diseases.
Industries:
Location:
Key people:
16
Funding Rounds
$328.8m
Money raised
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.
Location:
Key people:
- Paul Laikind **@vrtx.com
2
Funding Rounds
$13.8m
Money raised
A biopharmaceutical company developing therapeutics to attack cancer stem cells.
Industries:
Location:
Key people:
1
Funding Rounds
EpiBone is a biotechnology startup company developing bone reconstruction solutions using stem cells. Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig founded EpiBone in 2013 and the company is headquartered in New York City, New York.
Industries:
Location:
Key people:
8
Funding Rounds
$459.7m
Money raised
Silicon Valley-based genetic engineering startup.
Key people:
- Alex Pesch ****.*****@cellares.com
- Paul Dabrowski ****.*********@synthego.com
- Michael Dabrowski *******.*********@synthego.com
2
Funding Rounds
$82.0m
Money raised
Bionic is a company founded in 2019 by Idan Ninyo.
Industries:
Key people:
9
Funding Rounds
$262.0m
Money raised
A biotechnology company using genetic editing technologies to develop therapies for the treatment of cancer and genetic diseases.
Industries:
Location:
Key people:
2
Funding Rounds
$164.5m
Money raised
Develops novel cell and gene therapies with pharmacologic operating systems.
Industries:
Location:
Key people:
- Steve Shamah *******@obsidiantx.com
- Tariq Kassum *****@curie.bio
- Michael Gilman linkedin
3
Funding Rounds
$52.0m
Money raised
3T Biosciences is a biotechnology company developing immunotherapies.
Key people:
- Marvin Gee ******.***@3tbiosciences.com
- Luke Lee ****.***@ihcfunds.com
- Leah Sibener twitter
4
Funding Rounds
$30.0m
Money raised
Company manufacturing 3d printed pharmaceuticals based in San Francisco, CA
Industries:
Location:
Key people:
- Fred Parietti ****@multiplylabs.com
- Alice Melocchi *****@multiplylabs.com
1
Funding Rounds
$10.5m
Money raised
SmartPharm Therapeutics is a Cambridge, MA-based gene therapy company applying the next generation of non-viral DNA and RNA technologies to treat serious human diseases.
Industries:
3
Funding Rounds
$183.9m
Money raised
Bit.bio is a biotechnology company that aims to operate within human cells through means of coding and biology.
4
Funding Rounds
$5.1m
Money raised
Biological micro-pancreas for insulin-dependent diabetics company
Industries:
Key people:
4
Funding Rounds
$7.1m
Money raised
Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.
3
Funding Rounds
$109.0m
Money raised
Dyno Therapeutics is a company based in Cambridge, Massachusetts applying artificial intelligence to gene therapy, focused on adeno-associated virus capsid engineering.
Industries:
Key people:
- Adrian Veres ******.*****@dynotx.com
- Alan Crane ****.*****@dynotx.com
- Eric Kelsic ****.******@dynotx.com
5
Funding Rounds
$425.0m
Money raised
Tmunity Therapeutics is a biotechnology company developing t-cell immunotherapies for the treatment of human diseases.
Industries:
Location:
Key people:
- Dr. Yangbing Zhao linkedin
- Dr. Bruce Levine ******@capstantx.com
- Dr. Carl H. June linkedin
5
Funding Rounds
$14.5m
Money raised
Aegle Therapeutics Corporation, a regenerative medicine company isolating extracellular vesicles ("EVs") from allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat severe dermatological conditions, including burns and epidermolysis bullosa (“EB”).
Industries:
Location:
Key people:
- Shelley Hartman ********@aegletherapeutics.com
- Evangelos Badiavas *********@aegletherapeutics.com
- Robert Williamson ***********@aegletherapeutics.com
4
Funding Rounds
$46.7m
Money raised
Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.
1
Funding Rounds
$2.0m
Money raised
Allevi, formerly known as BioBots, is a technology company making 3 dimensional bioprinters and bioinks for their printers. The company was founded in 2014 and located in Philadelphia, Pennsylvania.
5
Funding Rounds
$19.7m
Money raised
OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.
2
Funding Rounds
$6.2m
Money raised
A biotechnology company with a focus on developing medical solutions with biomaterial. It was founded in 2015 and is located in Durham, North Carolina.
1
Funding Rounds
$3.9m
Money raised
Tempo Therapeutics is an interventional biomaterials for regenerative medicine company founded by Westbrook Weaver.
1
Funding Rounds
$1.7m
Money raised
Celdara Medical is a biotechnology company helping turn academic innovations into medical products.
2
Funding Rounds
$105.0m
Money raised
Eureka Therapeutics is a biotechnology company developing immunotherapies for the treatment of cancer.
Industries:
Location:
1
Funding Rounds
$13.2m
Money raised
A biotechnology company using tissue engineering to create biomaterials for repairing and regenerating the human body.
Industries:
Key people:
- Andrew E. Pelling ******.*******@utoronto.ca
- Charles M. Cuerrier *******.********@spiderwortbio.com
1
Funding Rounds
$12.8m
Money raised
Kiadis Pharma is a biotechnology company developing stem cell regenerative medicine treatments for blood cancers and blood disorders.
Industries:
Location:
Key people:
2
Funding Rounds
$82.0m
Money raised
Novadip Biosciences is a biotechnology company developing regenerative medicines using stem cells.
Industries:
Location:
Key people:
- Jean- François Pollet ********@corning.com
- Denis Dufrane *****.*******@novadip.com
2
Funding Rounds
$177.0m
Money raised
GentiBio, Inc. is a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology.
Industries:
Location:
1
Funding Rounds
$7.0m
Money raised
Gadeta is a biotechnology company developing immunotherapies for treating cancer.
Industries:
Key people:
6
Funding Rounds
$94.2m
Money raised
Coave Therapeutics is a genetic medicines developer founded in 2014.
Industries:
Location:
2
Funding Rounds
$110.0m
Money raised
Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.
Location:
Key people:
- Jeffrey Greve *******.*****@ensocell.com
3
Funding Rounds
$73.4m
Money raised
Ossium is building the world's first bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage
Industries:
Location:
Key people:
- Kevin Caldwell *****.********@ossiumhealth.com
- Erik Woods ****.*****@ossiumhealth.com
11
Funding Rounds
$37.9m
Money raised
Immusoft is a biotechnology company developing a platform for the insertion of therapeutic genes into immune cells for the treatment of a variety of genetic diseases.
9
Funding Rounds
$59.1m
Money raised
Locate Bio is a biotechnology developing cell and gene therapies for treating damaged tissues and organs.
Industries:
Location:
Key people:
3
Funding Rounds
$17.2m
Money raised
Trailhead Biosystems is a biotechnology company developing cell therapy products.
Industries:
Location:
Key people:
1
Funding Rounds
$15.0m
Money raised
A Canadian biotechnology company that develops specialty cell culture media, cell isolation systems and accessory products for life science research.
Industries:
Location:
Key people:
1
Funding Rounds
$2.0m
Money raised
A biotechnology company founded in 2006 and based in Baltimore, MD, that develops polymers to deliver DNA and RNA therapeutics.
Industries:
Location:
Key people:
4
Funding Rounds
$72.3m
Money raised
Abcuro develops immunotherapies to treat autoimmunity and cancer.
Key people:
- Alex Martin ****.******@abcuro.com
2
Funding Rounds
$112.0m
Money raised
Carisma Therapeutics is a biotechnology company founded in 2016 to bring the potheyr of adoptive cellular immunotherapy to solid tumor patients through a novel platform using chimeric antigen receptor macrophages (CARMA).
Industries:
Location:
Key people:
- Regina Hodits linkedin
- Margarita Chavez linkedin
- Steven Kelly ******.*****@carismatx.com
1
Funding Rounds
$4.7m
Money raised
Asimov is a startup that programs living cells with genetic circuits.
Location:
Key people:
- Alec Nielsen linkedin
- Douglas Densmore
- Raja Srinivas ****@asimov.com
2
Funding Rounds
$33.9m
Money raised
Refuge Biotechnologies is a biotechnology company that uses CRISPR and cell therapy technologies for treating cancer.
Industries:
Location:
Key people:
- Bing C Wang ****.****@refugebiotech.com
- Stanley Qi ***@stanford.edu
3
Funding Rounds
$15.4m
Money raised
Embody, Inc. is a regenerative medicine company focused on the development and commercialization of implantable medical devices to address unmet needs in soft tissue restoration and regeneration.
Industries:
Location:
4
Funding Rounds
$6.0m
Money raised
AGT is developing and commercializing gene and cell therapy and targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma.
Industries:
Location:
Key people:
2
Funding Rounds
$2.6m
Money raised
Precision therapeutics company developing epigenetic therapies that target arginine methylation in cancer.
3
Funding Rounds
$31.0m
Money raised
Mekonos is a company that creates cell-engineering platforms
Industries:
Location:
Key people:
1
Funding Rounds
$71.5m
Money raised
A2 Biotherapeutics, Inc. is a biotechnology research company developing T-cell therapies designed to attack solid tumors while sparing normal cells
4
Funding Rounds
$1.4m
Money raised
TeVido Biodevices is a biotechnology company developing cell therapy products for restoring lost skin pigment.
Industries:
Location:
Key people:
3
Funding Rounds
$200.0m
Money raised
PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.
1
Funding Rounds
$1.5m
Money raised
StemBioSys is a biotechnology company developing regenerative medicines using stem cells.
Industries:
Location:
Key people:
3
Funding Rounds
$70.8m
Money raised
Excision BioTherapeutics is a company founded in 2015 and headquartered in Philadelphia.
Industries:
Key people:
- Thomas Malcolm ********@excisionbio.com
- Rob Simmons linkedin
8
Funding Rounds
$84.5m
Money raised
Mogrify is developing tailored cellular conversions that power future cell therapies.
Industries:
Location:
1
Funding Rounds
$35.0m
Money raised
Tactiva Therapeutics is a biotechnology company developing cancer immunotherapies.
1
Funding Rounds
$22.0m
Money raised
Stemedica Cell Technologies is a biopharmaceutical company developing and manufacturing adult stem cells and stem cell factors for research institutions and hospitals for pre-clinical and clinical studies
Industries:
Location:
1
Funding Rounds
Biotherapeutics company focused on medicines for chronic inflammation, metabolic disease and autoimmune disease
Industries:
Location:
Key people:
4
Funding Rounds
$343.1m
Money raised
Encoded Therapeutics is a developer of genomics-driven precision medicine targeting and treating genetic diseases and disorders.
Industries:
Key people:
4
Funding Rounds
$2.6m
Money raised
Cytonus Therapeutics is a biotechnology company developing adaptive cellular therapies for treating immune-oncology and inflammatory diseases.
1
Funding Rounds
$60.0k
Money raised
Universal Cells is a biotechnology company developing regenerative medicine using stem cells.
1
Funding Rounds
$67.0m
Money raised
Qihan Biotech is a hangzhou-based biotech company focused on organ transplantation founded in 2017 by Luhan Yang.
1
Funding Rounds
$3.4m
Money raised
Anagenesis Biotechnologies is a biotechnology company developing pre-clinical stem cell therapies for treating genetic and age-related muscle degenerative diseases.
Industries:
Location:
1
Funding Rounds
$2.5m
Money raised
Targazyme is a biotechnology company focused on improving survival and quality of life for cancer patients using stem cell transplantation, immunotherapy, regenerative medicine, and gene therapy.